Propikacin
- Level
- Commodity
- Parent
- 51281600
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51281621This classification denotes an aminoglycoside antibiotic with the molecular formula C21H43N5O12, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9X6F5H479X, chemically known as uk 31,214 but generally known as propikacin, which bears US NIH Compound Identifier 68557. European Medicines Agency schedules Propikacin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10107MIG. The term PROPIKACIN is an International Non-Proprietary Name. PROPIKACIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule propikacin under HS 29419000 and SITC 54139. As of Q4 2014, PROPIKACIN remains the US FDA Preferred Term for this commodity. Propikacin bears US NLM identifiers UMLS ID C0610191 and NCI Concept Code C75063. SMILES: O(C1C(NC(CO)CO)CC(N)C(OC2OC(C(O)C(O)C2N)CN)C1O)C1OC(C(O)C(N)C1O)CO.
Same parent
Under 51281600 · 75Activities that produce or sell this
KBLI · 9Inherited from family 51280000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.